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Abstract
New modalities are available to visualize the small bowel
in patients with Crohn’s disease (CD). The aim of this
study was to compare the diagnostic yield of magnetic
resonance enteroclysis (MRE) and capsule endoscopy
(CE) to balloon-assisted enteroscopy (BAE) in patients
with suspected or established CD of the small bowel.
Consecutive, consenting patients ﬁrst underwent MRE
followed by CE and BAE. Patients with high-grade ste-
nosis at MRE did not undergo CE. Reference standard
for small bowel CD activity was a combination of BAE
and an expert panel consensus diagnosis. Analysis
included 38 patients, 27 (71%) females, mean age 36
(20–74) years, with suspected (n = 20) or established
(n = 18) small bowel CD: 16 (42%) were diagnosed with
active CD, and 13 (34%) by MRE with suspected high-
grade stenosis, who consequently did not undergo CE.
The reference standard defined high-grade stenosis in 10
(26%) patients. Sensitivity, specificity, positive predictive
value (PPV) and negative predictive value of MRE and
CE for small bowel CD activity were 73 and 57%, 90 and
89%, 88 and 67%, and 78 and 84%, respectively. CE was
complicated by capsule retention in one patient. MRE
has a higher sensitivity and PPV than CE in small bowel
CD. The use of CE is considerably limited by the high
prevalence of stenotic lesions in these patients.
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Crohn’s disease (CD) is a chronic inﬂammatory disorder
associated with both mucosal and transmural inﬂam-
mation of the bowel wall. CD can affect any part of the
gastrointestinal tract, but the small bowel is affected in
up to two-thirds of patients, with the distal ileum as the
most affected site. Until recently, CD of the small bowel
was assessed by upper gastrointestinal endoscopy, ileo-
colonoscopy, and conventional enteroclysis. However,
the armamentarium of imaging techniques for small
bowel involvement of CD has increased considerably in
recent years with the introduction of capsule endoscopy
(CE), balloon-assisted enteroscopy (BAE), and magnetic
resonance enteroclysis (MRE).
Already, CE has been shown to provide a signiﬁ-
cantly higher diagnostic yield than push enteroscopy and
conventional enteroclysis in patients with CD [1]. How-
ever, capsule retention in stenotic small bowel CD
hampers its use in these patients [2]. BAE, first intro-
duced in 2001 [3], combines endoscopic visualization of
the entire small bowel with the possibility for endoscopic
treatment of fibrotic strictures, and tissue sampling for
histological examination [4, 5]. Although BAE can be
considered as the reference standard, the lengthy and Correspondence to: Bart M. Wiarda; email: b.m.wiarda@mca.nl
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comfort, and need for conscious sedation limit its use [6].
MRE allows optimal visualization of soft tissues with
multiplanar imaging capabilities and has already been
proven to have additional value compared to endoscopic
techniques in CD patients [7–10]. In theory, MRE may
be a good alternative for CE and BAE in CD patients
with suspected small bowel involvement.
To our knowledge, no study has simultaneously
compared CE, MRE, and BAE in one patient population
with suspected or established CD. Therefore, the aim of
the present study was to compare the diagnostic yield of
MRE and CE to BAE as reference standard in patients
with suspected or established CD.
Patients and methods
Study population
For this prospective study, patients were recruited at the
departments of gastroenterology of the Medical Center
Alkmaar and the Erasmus University Medical Center
Rotterdam, The Netherlands. Patients were eligible for
inclusion if they had suspected or established CD and
needed visualization of the small bowel because of sus-
pected small bowel disease activity. Exclusion criteria
were age <18 or >75 years, abdominal surgery in the
6 weeks prior to inclusion, clinical suspicion of signiﬁ-
cant small bowel obstruction, suspicion of an intra-
abdominal abscess, pregnancy or breastfeeding, inability
to swallow the video capsule, presence of a pacemaker or
cardioversion device, or a history of contrast media
reaction or allergy. Patients with severe concomitant
disease with limited life expectancy or with a psychiatric,
addictive, or any disorder compromising the ability to
give informed consent were also excluded. The institu-
tional review boards of the participating hospitals
approved the study. All patients gave written informed
consent prior to inclusion.
From January 2007 to July 2009, 67 patients were
eligible for inclusion; 41 agreed to participate and were
included after providing informed consent. Three
patients were excluded after inclusion: one because of no
attendance at examinations and two because of marked
deterioration of their clinical condition preventing them
from undergoing the subsequent examinations. Thus, 38
consecutive patients were eligible for evaluation: 20
(53%) with suspected and 18 (47%) with established CD.
Eleven (29%) patients were male, and the mean age was
36 (range 20–74) years (Table 1). MRE, CE, and BAE
were performed within a median of 22 (4–112) days, and
in five (13%) patients, this interval was longer than
3 weeks. The median follow-up was 14 (7–36) months.
Patient disease activity was determined using the CD
activity index at the time of inclusion. Currently, no
validated enteroscopic small bowel CD severity scale
exists, so small bowel lesions were deﬁned as (1) absent:
no disease activity; (2) mild: erythematous and/or
edematous mucosa and/or small ulcerative lesions
(<0.5 mm) within otherwise normal appearing mucosa;
(3) moderate: larger ulcerative lesions (‡0.5 mm and
<20 mm); or (4) severe: large ulcerative lesions
(‡20 mm) and/or signiﬁcant stenotic lesions, with or
without macroscopic signs of inﬂammation. Changes in
medical therapy, surgery, or other therapeutic measures
were documented.
Study modalities
For evaluation, the small bowel was divided into four
segments; duodenum, jejunum, proximal ileum, and
distal (last 30 cm) ileum. For the qualitative assessment,
image quality was graded on a three-point scale (non-
diagnostic study, diagnostic study albeit with artifacts,
diagnostic study of good quality). Investigators per-
forming the examinations received the same clinical
information but were blinded to the results of the other
diagnostic procedures performed for the study.
All patientsﬁrst underwent MRE, followedbyCE and
BAE with the aim of having all investigations completed
within 3 weeks. For early diagnosis of high-grade small
bowel stenosis, MRE was performed ﬁrst. During the
whole study, high-grade stenosis was deﬁned as a small
bowel lumen of <10 mm with maximal bowel distention,
and these patients did not undergo CE. If MRE deﬁned a
luminal stenosis of 10–14 mm, a patency capsule (Agile
Patency Capsule, Given Imaging Limited) was applied
beforeCE.Failureofthepatencycapsuletopassthesmall
bowel in <16 h based on plain abdominal X-ray was
considered compatible with the presence of high-grade
stenosis, and CE was subsequently not performed.
MRE. MRE was performed as previously described [11].
In brief, after bowel preparation, 1000–3000 ml 0.5%
methylcellulose solution was infused at a rate of
60–150 ml/min via a nasoduodenal catheter for optimal
small bowel distension. The MR protocol consisted of
MR fluoroscopy, fat-saturated True FISP, and HASTE
sequences as pre- and post-contrast T1-weighted VIBE
sequences after intravenous administration of 0.1 mmol/
kg of body weight of gadobutrol (Gadovist, Bayer
Schering, Berlin, Germany). Butylscopolamine bromide
Table 1. Patient characteristics
Total
(n = 38)
Suspected CD
(n = 20)
Known CD
(n = 18)
Age (years) 36 (20–74) 31 (20–54) 43 (28–74)
Male (%) 11 (29) 6 (30) 5 (28)
Duration
of CD (months)
68 (1–204) 44 (1–204) 91 (24–192)
CDAI 73 (22–147) 78 (22–147) 66 (34–134)
CD Crohn’s disease, CDAI Crohn’s disease activity index
398 B. M. Wiarda et al.: MR enteroclysis and capsule endoscopy(Buscopan, Boehringer, Ingelheim, Germany), 20 mg,
used as a spasmolytic, was injected before the injection of
gadobutrol. MRE studies were evaluated on a Picture
Archiving and Communications System station (PACS,
AGFA IMPAX version 4.5 service pack 5, Mechelen,
Belgium) by a radiologist with an experience of >200
MRE studies. Electronic calipers were used for measure-
ments. Bowel distension was graded as either insufficient
(i.e., collapsed bowel loops) or sufficient for diagnosis
(small bowel lumen measuring > 0.5 cm). For MRE, the
duodenum was defined as the first 20 cm of the small
bowel;jejunumwasconsideredassmallbowelloopsleftof
animaginarylinefromtheliverdometotheroofoftheleft
acetabulum; all bowel loops located right of this imagi-
nary line were regarded as ileum; and the terminal ileum
was defined as the last 30 cm of the ileum. Disease activity
was based on the presence or absence of bowel wall
thickness >4 mm, intramural and mesenteric edema,
mucosal hyperemia, wall enhancement and enhancement
pattern and transmural ulcerations and fistula formation.
CE. CE was performed as previously described [12]. In
brief, after bowel preparation with 1 l Klean-Prep
(Norgine Ltd., Marburg, Germany), the patient swal-
lowed the capsule (PillCam type SB, Given Imaging
Limited, Yokneam, Israel). After 8 h, the belt with the
hard disk and the sensor array were removed. In case of
doubt about passage of the capsule through the whole
bowel, an X-ray of the abdomen was performed 1 week
after ingestion. CE recordings were evaluated on a ded-
icated workstation (Rapid 4, Given Imaging Limited,
Yokneam, Israel) by a gastroenterologist with extensive
experience (>500 CE procedures). Gastric transit time,
small intestinal transit time, and viewing time were
recorded for each procedure. For CE, the duodenum was
defined as the first 20 min of the small bowel; the time
between start jejunum and start terminal ileum was
divided into two for the transition between jejunum and
ileum; and the terminal ileum was defined as the last
30 min of the ileum.
BAE. After an overnight fast and bowel preparation with
4 l of Klean-Prep (Norgine Ltd., Marburg, Germany),
BAE was performed (Fujinon EN-450P5 or EN-450T5,
Saitama, Japan) by one of two experienced enteroscopists,
bothhavingperformed>200BAEprocedures.Duringthe
procedure, conscious sedation was applied using midazo-
lam (Dormicum, Roche, Woerden, Netherlands), with or
without fentanyl (Janssen-Cilag, Tilburg, Netherlands),
and on withdrawal, butylscopalamine (Buscopan, Boeh-
ringer, Ingelheim, Germany) was administered. Most BAE
procedures were performed via the anal approach; in se-
lected cases with clinical suspicion of proximal small bowel
pathology,ﬁrstanoralapproachwasperformedduringthe
same procedure. Insertion depths were estimated using the
method described by May et al. [4]. The complete studies
were taped on digital video and the duration of each pro-
cedure noted. For BAE, the duodenum was defined as the
first 20 cm distal from the bulb; jejunum as 20–200 cm
distalfromthebulbbyoraland130–230 cmproximalfrom
theileocecalvalveorileostomabyanalapproach;proximal
ileum as 200–300 cm from the bulb by oral and 30–130 cm
fromtheileocecalvalveorileostomabyanalapproach;and
the terminal ileum as the last 30 cm of the ileum. Biopsy
sampling was performed in a standard fashion. Samples
were taken if lesions were found during BAE or to rule out
inflammation in endoscopically normal appearing small
bowel segments.
Reference standard and expert panel
The reference standard consisted of (1) small bowel
ﬁndings at BAE in those small bowel segments visualized
by BAE and (2) an expert panel diagnosis for the
remaining small bowel segments not visualized by BAE.
The expert panel also re-evaluated segments for which
BAE was negative and MRE and/or CE diagnosed small
bowel lesion(s). This expert panel consisted of two
experienced gastroenterologists, not involved in primary
reading of the examinations evaluated in this study nor
in the management of the patients included. Separately,
both experts were presented with the anonymized, full
patient medical history, clinical status and the written
reports of BAE, MRE and CE with the most important
images. Consensus was subsequently reached on the
bowel segments scored discordantly. The patient medical
history and clinical status included the indication for the
diagnostic work-up, laboratory ﬁndings and, if available,
results of histopathological examination together with
the results of the three diagnostic procedures. For all
cases, both experts came to a ﬁnal consensus diagnosis.
Statistical analysis
The sensitivity, speciﬁcity, positive predictive value
(PPV), and negative predictive value (NPV) for MRE
and CE were calculated compared to the reference
standard.
No direct comparative data for the different tech-
niques in the studied patient populations were available,
so we estimated that the difference for detection of dis-
ease activity in CD would be 30% in favor of the refer-
ence standard. To detect a signiﬁcant difference with a
power of an alpha of 0.05 and beta of 0.20 required a
study population of at least 33 patients.
Results
BAE and reference standard diagnosis
All patients underwent BAE, which was performed by a
combined proximal and distal approach in 19 (50%), and
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studies were of good diagnostic quality. The median
small bowel insertion depth with BAE was proximal 335
(200–460) cm and distal 98 (5–240) cm. The mean
duration of BAE was 70 (30–150) min. BAE visualized
98/152 (65%) segments of the small bowel. The duode-
num and jejunum were both visualized in 19/38 (50%)
patients, the proximal ileum in 22/38 (58%) patient, and
the distal ileum in 38/38 (100%) patients. No complica-
tions were noted during or after the BAE procedures.
BAE revealed small bowel lesions in 16 (42%) patients
(Table 2), confirmed as active CD by the expert panel. In
the remaining 22 patients defined as normal by BAE, the
expert panel did not change this diagnosis based on the
data provided by MRE and CE. BAE diagnosed non-
CD-related pathology in two patients; a pseudomela-
notic colon and a Trichuris infection.
MRE
The mean duration of MRE was 53 (37–91) min. All
studies were of good diagnostic quality with sufﬁcient
small bowel distension. The MRE procedure was com-
plicated in four (11%) patients by vomiting and in one
(3%) patient by a mild allergic rash after intravenous
contrast injection. In two patients, vomiting resulted
from the presence of a high-grade small bowel stenosis
and in one patient from a low-grade small bowel stenosis.
The mean evaluation time was 9 (6–20) min. Visualiza-
tion and evaluation of the four pre-deﬁned small bowel
segments was possible in all patients. MRE found evi-
dence for CD small bowel disease activity in 16 (42%)
patients (Table 2). This activity was confirmed by the
gold diagnostic standard for 14 (88%) (Table 3). MRE
revealed extramural abnormalities in four (11%) patients:
a mesenteric abscess in two, an abdominal-enteral fistula
in one, and intra-abdominal adhesions in one patient.
MRE did not reveal non-CD-related pathology.
CE
MRE raised the suspicion of small bowel stenosis in 14
(37%) patients. In 11 of them, this stenosis was deﬁned as
high grade, and consequently these patients were
excluded from CE. The remaining three patients had a
suspected low-grade stenosis at MRE and underwent
patency capsule testing. This patency capsule passed in
one patient and was retained in two. Thus, 13 (34%)
patients were excluded from CE because of small bowel
stenosis and 25 (66%) underwent CE. CE visualized the
complete small bowel in all but one patient (4%; capsule
retention). The stenosis in this patient had not been de-
tected during MRE, and the patient therefore had not
been tested with a patency capsule. The capsule could not
be removed during subsequent BAE and was removed
surgically. The capsule retention was caused by a high-
grade ileal stenosis. All CE procedures were of good
diagnostic quality. The mean evaluation time was 23 (14–
48) min. CE found evidence for CD small bowel disease
activity in 6 (24%) patients (Table 2). This activity was
confirmed by the gold diagnostic standard for 4 (67%)
(Table 3). CE revealed presumed non-CD-related
pathology in one patient with erosive gastritis.
MRE and CE compared with reference standard
MRE showed a higher rate of detection of moderate to
severe CD activity compared to CE (17 vs. 3%). How-
ever, the exclusion of patients with suspected stenotic
disease for subsequent CE (Figs. 1, 2) largely influenced
this outcome. CE showed a higher detection rate of le-
sions in mild CD activity patients (Table 2; Fig. 3).
These results (Table 3) correspond with a sensitivity of
74 and 57%, specificity of 90 and 89%, PPV of 88 and
67%, and NPV of 78 and 84%, for detection of small
bowel CD lesions by MRE and CE, respectively.
BAE diagnosed ten high-grade stenotic lesions in 10
(26%) patients: eight stenoses in distal ileum, one in
jejunum, and one in proximal ileum. MRE reported 15
stenotic segments in 13 patients (34%). The detection of
high-grade small bowel stenosis by MRE had a sensi-
tivity of 91%,9 9 % speciﬁcity, 77% PPV, and 96% NPV.
MRE was false negative in one patient, leading to cap-
sule retention resulting from a high-grade stenosis in the
distal jejunum.
Discussion
The results of this prospective study demonstrate that
MRE has a higher overall sensitivity and PPV, for small
Table 2. Crohn’s disease activity of MRE and CE
Reference
standard
a n (%)
MRE diagnosis
n (%)
CE diagnosis
n (%)
No disease activity 19 (50) 22 (58) 19 (50)
Mild CD 7 (18) 3 (8) 4 (11)
Moderate CD 7 (18) 6 (16) 2 (5)
Severe CD 5 (13) 7 (18) 0 (0)
Not performed 0 0 (0) 13 (34)
Total 38 (100) 38 (100) 38 (100)
a The reference standard consisted of (1) small bowel findings at BAE in
those small bowel segments visualized by BAE and (2) an expert panel
diagnosis for the remaining small bowel segments not visualized by
BAE
Table 3. Crohn’s disease diagnosis by MRE and CE per patient in
comparison with reference standard
MRE diagnosis n (%) CE diagnosis n (%)
True positive 14 (37) 4 (16)
True negative 17 (45) 16 (64)
False positive 2 (5) 2 (8)
False negative 5 (13) 3 (12)
Total 38 (100) 25 (100)
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pected or established CD with suspected small bowel
activity. In these patients, the use of CE is limited by the
risk of capsule retention. The ﬁndings of a higher sensi-
tivity and PPV in staging more advanced CD and
reduced accuracy in staging mild CD activity for MRE as
compared to CE seem to accord with an earlier study by
Tillack et al. [ 13]. However, in the present study, CE was
prohibited in one-third of patients because of suspected
high-grade small bowel stenotic disease, contributing to
the result that MRE performed better compared to CE in
patients with more advanced CD.
The high prevalence of high-grade stenoses is in line
with the ﬁndings of Voderholzer et al. in a CE study of 15
patients (27%) with established CD [14]. The frequency
of high-grade stenosis varied depending on CD stage and
ranged from 1.4% in patients with suspected CD to 13%
in known CD [15, 16]. The possible presence of high-
grade small bowel stenosis is the major drawback of CE,
necessitating the exclusion of functional stenoses prior to
CE. Nevertheless, even with pre-exclusion of high-grade
small bowel stenosis, capsule retention may occur, as
illustrated by one of our patients.
Capsule retention in these patients is a major adverse
event, requiring additional intervention that is a burden
and a risk for the patient and that generates extra costs
[17]. In our opinion, the increased risk of capsule reten-
tion in these patients outweighs the higher accuracy of
CE in staging mild CD. Although MRE has a high
diagnostic yield for stenotic CD, it can overstage this
condition. MRE indicated small bowel stenoses in 13
patients, but in three patients, BAE did not confirm this.
Fig. 1. 48-Year-old male patient with known CD for 20 years
and postoperative ileocecal resection. Patient complained of
abdominal pain. MRE showed on coronal T1 3d fat-sat image
(A) after contrast injection, three active segments of CD
(arrows) with bowel wall thickening, increased contrast
enhancement, irregular mucosa, high-grade stenosis, and
increased mesenterial vascularization (comb sign). CE was
not performed because of the high-grade small bowel ste-
nosis. BAE (B) showed ulcerations (arrows) in the terminal
ileum. The proximal segments could not be visualized
because of the high-grade small bowel stenosis.
Fig. 2. 35-Year-old male patient without medical history and
with suspected CD. Patient complaints were abdominal pain
in the right lower quadrant. MRE showed coronal T2 HASTE
image with small bowel thickening in the terminal ileum with
high-grade stenosis (arrow). Extramural abscess medial of
the terminal ileum (asterisk). CE was not performed because
of the high-grade small bowel stenosis. BAE (not shown)
showed swollen terminal ileum, without the possibility of
cannulation.
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bowel stenosis, the patency capsule was retained and a
high-grade ileal stenosis identified during surgery at
1 year of follow-up.
An advantage of MRE compared to the other two
modalities is the visualization of extramural small bowel
disease, which can be of additional value in staging CD
and determining therapeutic options. In this study, MRE
detected signiﬁcant extramural abnormalities in 8% of
patients. A disadvantage of MRE is that some patients
do not tolerate the oral preparation and/or small bowel
distension, especially those with high-grade small bowel
stenosis. This intolerance may lead to insufﬁcient small
bowel distension and visualization, and consequently to
reduced sensitivity of MRE for small bowel pathology.
We performed enteroclysis to obtain optimal distension
of the small bowel. Masselli et al. [18] concluded that
MRE was superior to MR enterography in detection of
milder superficial pathology. Another study presented by
Negaard et al. [19] showed comparable results of MRE
to MR enterography in the terminal ileum, but the study
defined MRE as MR of the small bowel after transpor-
tation of the patient to the MR unit following conven-
tional enteroclysis. In our experience, bowel distention
Fig. 3. 39-Year-old female patient with known CD and post-
operative ileocecal resection 3 years earlier. Patient complaints
were abdominal pain and diarrhea. MRE showed on coronal T1
3dfat-satimage(A)aftercontrastinjection,normalanastomosis
(arrows) of the neo-ileocecal junction without bowel wall thick-
ening or increased contrast enhancement. CE (B) and BAE (C)
both indicated superficial ulcerations on the level of the anasto-
mosis (arrows). No other abnormalities were diagnosed.
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infusion rate, and small bowel wall thickening therefore
can be missed with this type of MR procedure.
This study has some limitations. First, the order of
the examinations was pre-determined, and MRE was
used to rule out high-grade stenosis before patients had
CE to prevent capsule retention. Second, the study
population was relatively small, and a proportion of
patients did not undergo CE because of a high-grade
stenosis. Because of this limited number, signiﬁcance
could not be calculated. Third, BAE could not visualize
all small bowel segments in all patients, and an expert
panel was therefore asked to establish a ﬁnal diagnosis in
a subset of patients. The bias such a panel may introduce
can have two effects: (1) weakening the study because of
subjectivity or (2) strengthening the study because the
diagnosis of CD, or disease activity assessment, is often
based on multiple diagnostic tests. The major strength of
the study is the head-to-head comparison of MRE and
CE to a reference standard including BAE, suggesting
that an expert panel is an acceptable reference standard.
A fourth limitation is the fact that not all procedures
were performed within the three-week time frame. The
prolonged interval between the investigations might have
inﬂuenced the ﬁndings in some cases.
From the results, we conclude that MRE could be a
ﬁrst-choice non-invasive diagnostic procedure in patients
with suspected small bowel CD, followed by CE or BAE,
depending on (1) the outcome with MRE and/or (2) the
need for histopathological ﬁndings. The high incidence
of small bowel stenosis in these patients prohibits the use
of CE as a diagnostic modality.
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